Here, our analysis showed a negative association between RECK expression and mRNAsi for cancer stem cell scores, which implied that there was a positive correlation between high expression levels of RECK and a decreased impact of medicine resistance, diminished cancer recurrence, and a more favorable prognosis. The gene discussed is RECK; the disease is cancer.